Literature DB >> 11862317

PPARgamma and insulin sensitivity: too much and too little of a good thing.

Friedrich C Luft1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11862317     DOI： 10.1007/s00109-001-0309-z

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  10 in total

Review 1.  Roles of PPARs in health and disease.

Authors:  S Kersten; B Desvergne; W Wahli
Journal:  Nature       Date:  2000-05-25       Impact factor: 49.962

Review 2.  Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists.

Authors:  J M Olefsky
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 3.  IRS proteins and beta-cell function.

Authors:  D J Burks; M F White
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

Review 4.  Genetic determinants of type 2 diabetes mellitus.

Authors:  C P Busch; R A Hegele
Journal:  Clin Genet       Date:  2001-10       Impact factor: 4.438

Review 5.  Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review.

Authors:  J M Malinowski; S Bolesta
Journal:  Clin Ther       Date:  2000-10       Impact factor: 3.393

6.  Interaction effect between common polymorphisms in PPARgamma2 (Pro12Ala) and insulin receptor substrate 1 (Gly972Arg) on insulin sensitivity.

Authors:  Michael Stumvoll; Norbert Stefan; Andreas Fritsche; Alexander Madaus; Otto Tschritter; Matthias Koch; Fausto Machicao; Hans Häring
Journal:  J Mol Med (Berl)       Date:  2001-09-15       Impact factor: 4.599

7.  Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.

Authors:  A Okuno; H Tamemoto; K Tobe; K Ueki; Y Mori; K Iwamoto; K Umesono; Y Akanuma; T Fujiwara; H Horikoshi; Y Yazaki; T Kadowaki
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

8.  Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes.

Authors:  T Yamauchi; H Waki; J Kamon; K Murakami; K Motojima; K Komeda; H Miki; N Kubota; Y Terauchi; A Tsuchida; N Tsuboyama-Kasaoka; N Yamauchi; T Ide; W Hori; S Kato; M Fukayama; Y Akanuma; O Ezaki; A Itai; R Nagai; S Kimura; K Tobe; H Kagechika; K Shudo; T Kadowaki
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

9.  A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies.

Authors:  K Almind; G Inoue; O Pedersen; C R Kahn
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

10.  A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.

Authors:  S S Deeb; L Fajas; M Nemoto; J Pihlajamäki; L Mykkänen; J Kuusisto; M Laakso; W Fujimoto; J Auwerx
Journal:  Nat Genet       Date:  1998-11       Impact factor: 38.330
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.